The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121749773 12174977 3 F 201511 20160719 20160314 20160727 EXP US-GLAXOSMITHKLINE-US2016033295 GLAXOSMITHKLINE 70.00 YR F Y 0.00000 20160727 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121749773 12174977 1 PS ADVAIR DISKUS FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Respiratory (inhalation) UNK UNK, BID 21077 INHALATION POWDER BID
121749773 12174977 2 SS ADVAIR DISKUS FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 1 PUFF(S), BID UNKNOWN 21077 1 DF INHALATION POWDER BID
121749773 12174977 3 SS REQUIP ROPINIROLE HYDROCHLORIDE 1 Oral 2 MG, TID UNKNOWN 0 2 MG TABLET TID
121749773 12174977 4 SS REQUIP ROPINIROLE HYDROCHLORIDE 1 0 TABLET
121749773 12174977 5 SS REQUIP ROPINIROLE HYDROCHLORIDE 1 0 TABLET
121749773 12174977 6 SS VENTOLIN HFA ALBUTEROL SULFATE 1 2 PUFF(S), PRN 0 2 DF
121749773 12174977 7 SS VENTOLIN HFA ALBUTEROL SULFATE 1 0
121749773 12174977 8 SS REQUIP XL ROPINIROLE HYDROCHLORIDE 1 2 MG, QD U UNKNOWN 0 2 MG PROLONGED-RELEASE TABLET QD
121749773 12174977 9 C CARBIDOPA. CARBIDOPA 1 U 0
121749773 12174977 10 C FUROSEMIDE. FUROSEMIDE 1 U 0
121749773 12174977 11 C LEVOTHYROXINE. LEVOTHYROXINE 1 U 0
121749773 12174977 12 C KLONOPIN CLONAZEPAM 1 U 0
121749773 12174977 13 C LOVASTATIN. LOVASTATIN 1 U 0
121749773 12174977 14 C TIZANIDINE. TIZANIDINE 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121749773 12174977 1 Chronic obstructive pulmonary disease
121749773 12174977 2 Emphysema
121749773 12174977 3 Parkinson's disease
121749773 12174977 4 Restless legs syndrome
121749773 12174977 5 Essential tremor
121749773 12174977 6 Chronic obstructive pulmonary disease
121749773 12174977 7 Emphysema
121749773 12174977 8 Restless legs syndrome

Outcome of event

Event ID CASEID OUTC COD
121749773 12174977 OT
121749773 12174977 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
121749773 12174977 Asthenia
121749773 12174977 Back injury
121749773 12174977 Bladder catheterisation
121749773 12174977 Bronchitis
121749773 12174977 Cystitis
121749773 12174977 Emphysema
121749773 12174977 Fall
121749773 12174977 Hip arthroplasty
121749773 12174977 Hyperhidrosis
121749773 12174977 Knee arthroplasty
121749773 12174977 Lip blister
121749773 12174977 Memory impairment
121749773 12174977 Muscle spasms
121749773 12174977 Nausea
121749773 12174977 Oral mucosal blistering
121749773 12174977 Spinal operation
121749773 12174977 Vertebral osteophyte

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121749773 12174977 8 201606 0